Many studies have used genomic and transcriptomic datasets and immunohistochemical analysis of patient tumors to examine expression of the IGF pathway in breast cancer and its association with clinical outcomes [60,61,62,63,64]. The gene discussed is IGF1; the disease is breast cancer.